Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bevespi Aerosphere 7.2microg / 5microg/dose pressurised inh
0301040AABBAAAA
|
Bevespi | Glycopyrronium/formoterol | Respiratory System | 22,667 |
|
Trimbow NEXThaler 88microg/5microg/9microg/dose dry pdr inh
0302000AABBACAC
|
Trimbow | BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | Respiratory System | 22,214 |
|
Carbocisteine 750mg capsules
0307000J0AAAJAJ
|
Carbocisteine | Carbocisteine | Respiratory System | 22,118 |
|
Soprobec 50micrograms/dose inhaler
0302000C0BTAABE
|
Soprobec | Beclometasone dipropionate | Respiratory System | 21,347 |
|
Tiotropium bromide 18microgram inhalation pdr caps with dev
0301020Q0AAAAAA
|
Tiotropium bromide | Tiotropium bromide | Respiratory System | 21,089 |
|
Fluticasone 250mcg/dose / Salmeterol 25mcg/dose inh CFC free
0302000N0AABGBG
|
Fluticasone propionate (Inhalation) | Fluticasone propionate (Inhalation) | Respiratory System | 20,688 |
|
Flutiform 50micrograms/dose / 5micrograms/dose inhaler
0302000N0BDACBL
|
Flutiform | Fluticasone propionate (Inhalation) | Respiratory System | 20,430 |
|
Trimbow 172microg/dose / 5microg/dose / 9microg/dose inh
0302000AABBABAB
|
Trimbow | BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | Respiratory System | 19,886 |
|
Soprobec 200micrograms/dose inhaler
0302000C0BTABBV
|
Soprobec | Beclometasone dipropionate | Respiratory System | 19,712 |
|
Easyhaler Budesonide 200micrograms/dose dry powder inhaler
0302000K0BGABAG
|
Easyhaler (Budesonide) | Budesonide | Respiratory System | 18,860 |
|
Uniphyllin 400mg prolonged-release tablets
0301030S0BKAAAR
|
Uniphyllin | Theophylline | Respiratory System | 18,808 |
|
AirFluSal 25micrograms/dose / 125micrograms/dose inhaler
0302000N0BGABBF
|
AirFluSal | Fluticasone propionate (Inhalation) | Respiratory System | 18,525 |
|
Clenil Modulite 250micrograms/dose inhaler
0302000C0BPADBW
|
Clenil Modulite | Beclometasone dipropionate | Respiratory System | 18,312 |
|
Promethazine 5mg/5ml oral solution sugar free
0304010W0AAAPAP
|
Promethazine hydrochloride (Systemic) | Promethazine hydrochloride | Respiratory System | 18,179 |
|
Airomir 100micrograms/dose Autohaler
0301011R0BMABBU
|
Airomir | Salbutamol | Respiratory System | 17,809 |
|
Spiriva 18microgram inhalation pdr caps with HandiHaler
0301020Q0BBAAAA
|
Spiriva | Tiotropium bromide | Respiratory System | 17,777 |
|
Fluticasone 50microg / Salmeterol 25microg/dose inh CFC free
0302000N0AABEBE
|
Fluticasone propionate (Inhalation) | Fluticasone propionate (Inhalation) | Respiratory System | 17,498 |
|
Codeine 15mg/5ml linctus sugar free
0309010C0AAADAD
|
Codeine phosphate (Cough) | Codeine phosphate | Respiratory System | 17,247 |
|
Qvar 100 Autohaler
0302000C0BJADBH
|
Qvar | Beclometasone dipropionate | Respiratory System | 17,035 |
|
Jext 300micrograms/0.3ml (1 in 1,000) inj auto-injectors
0304030C0BHABA3
|
Jext | Adrenaline | Respiratory System | 16,560 |
|
EpiPen Jr. 150microg/0.3ml (1 in 2,000) inj auto-injectors
0304030C0BEAAA2
|
EpiPen | Adrenaline | Respiratory System | 16,474 |
|
Levocetirizine 5mg tablets
0304010ACAAAAAA
|
Levocetirizine | Levocetirizine | Respiratory System | 15,951 |
|
Tiotropium bromide 2.5micrograms/dose inhalation soln cart
0301020Q0AAAEAE
|
Tiotropium bromide | Tiotropium bromide | Respiratory System | 15,757 |
|
Combisal 25micrograms/dose / 125micrograms/dose inhaler
0302000N0BLABBF
|
Combisal | Fluticasone propionate (Inhalation) | Respiratory System | 15,640 |
|
Qvar 50micrograms/dose Easi-Breathe inhaler
0302000C0BJAEBG
|
Qvar | Beclometasone dipropionate | Respiratory System | 15,471 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.